Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (6) Janz, Martin Dr. (9) Kammertöns, Thomas Dr. (4) Kopp, Joachim Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (12) Pezzutto, Antonio Prof. Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (3) Wolf, Susanne Dr. (2) Wollert-Wulf, Brigitte (3) (-) Daniel, Peter Prof. Dr. (2) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) 2002 (1) 2005 (1) (-) 2006 (2) 2010 (1) 2011 (2) (-) 2015 (3) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2022 (1) (-) Biology of Malignant Lymphomas (1) Computational Regulatory Genomics (2) Developmental Biology / Signal Transduction (2) Genetics and Genomics of Cardiovascular Diseases (1) Genome Diversification & Integrity (1) Immune Regulation and Cancer (1) (-) Molecular Immunology and Gene Therapy (4) Molecular Physiology of Somatic Sensation (1) Proteome Dynamics (18) Proteomics and Metabolomics (2) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (1) RNA Biology and Posttranscriptional Regulation (1) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (2) Translational Oncology of Solid Tumors (1) 5 Results: Active Filter: Daniel, Peter Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Biology of Malignant LymphomasMolecular Immunology and Gene Therapy20062015 Sort: Result score Newest to oldest Oldest to newest November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel May 01, 2015 / J Mol Med Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma C. Chumduri B. Gillissen A. Richter A. Richter A. Milojkovic T. Overkamp A. Mueller C. Pott P.T. Daniel April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
May 01, 2015 / J Mol Med Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma C. Chumduri B. Gillissen A. Richter A. Richter A. Milojkovic T. Overkamp A. Mueller C. Pott P.T. Daniel
April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein